
PYC
PYC.AXPYC Therapeutics Limited Price (PYC.AX)
Stock Price
Market Cap
Fetching Data...
Enterprise Value
Fetching Data...
Volume
Fetching Data...
Shares Outstanding
3,935,910,623
(21.1491)%Description
PYC Therapeutics Limited, a drug-development company, engages in the discovery and development of drug solutions in the areas of ribonucleic acid therapeutics in Australia. The company's preclinical development programs include VP-001, drug program for retinitis pigmentosa type 11; and PYC-001, a drug program for the treatment of autosomal dominant optic atrophy. It also focuses on the development of programs for kidney, retinal, and central nervous system diseases. PYC Therapeutics Limited has academic-industry collaborations with Murdoch University to... Read More
Sector: Healthcare
- Previous Close Fetching Data...
- Range $1.03-2
- Market Cap 723.24M
- Enterprise Value No Data
- Avg Volume Fetching Data...
- P/E Ratio Fetching Data...
- Dividend Yield Fetching Data...
Industry: Biotechnology
- ceo: Dr. Rohan Hockings G.D.L.P, J.D., MBBS, MBBS (Hons.)
- IPO Date: March, 30, 2005
- Country: AU
- Currency: AUD
- Headquaters: Nedlands, WA
- Employees: 23
- Revenue from each product or segment:
Product or Segment | Value: | % - Total | Last 3Y: |
---|

- Revenue by Region
Product or Segment | Value: | % - Total | Last 3Y: |
---|
